Peringkat dalam Saham
#3837
BillionToOne, Inc. is a specialized diagnostics company that innovates by... BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the precision of disease detection. Their product portfolio includes: UNITY Complete: A non-invasive prenatal screen that assesses a fetus's risk for aneuploidies, recessive genetic conditions, and fetal antigens, all from a simple maternal blood sample. Northstar Select: A liquid biopsy test designed to pinpoint specific mutations present in tumors, encompassing deletions, insertions, and point mutations. Northstar Response: A diagnostic tool that enables continuous tracking of cancer progression through detailed methylation assessment. Established in 2016, BillionToOne, Inc. conducts its operations from its headquarters located in Menlo Park, California.
Harga Saham
$99.89
Terakhir disinkronkan: 2026-08-25
Kapitalisasi Pasar
$4.59B
Perdagangan BillionToOne, Inc. (BLLN)
Harga BLLN dengan kapitalisasi pasar B
Kapitalisasi pasar dari BillionToOne, Inc.(BLLN)
Kapitalisasi Pasar: $4.59B
Per August 2026, BillionToOne, Inc. memiliki kapitalisasi pasar sebesar $4.59B. Ini menjadikan BillionToOne, Inc. sebagai perusahaan 3837th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar BillionToOne, Inc. dari 2025 hingga 2026
BLLN dibandingkan dengan 5 teratas stocks paling populer
| Harga BLLN |
|
Aset B |
Pasar B |
Hasil |
|
|
|
|
$5.152T
|
+112,045.64%
|
|
|
|
|
$4.537T
|
+98,649.80%
|
|
|
|
|
$4.169T
|
+90,630.29%
|
|
|
|
|
$3.642T
|
+79,177.00%
|
|
|
|
|
$2.805T
|
+60,945.34%
|
